You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
宣泰醫藥(688247.SH)IPO定價9.37元/股 8月16日開啟申購
格隆匯 08-14 18:06

格隆匯8月14日丨宣泰醫藥(688247.SH)公佈,發行人與保薦機構(主承銷商)根據網下發行詢價報價情況,綜合評估公司合理投資價值、可比公司二級市場估值水平、所屬行業二級市場估值水平等方面,充分考慮網下投資者有效申購倍數、市場情況、募集資金需求及承銷風險等因素,協商確定此次發行價格為9.37元/股。此次網上申購時間為8月16日(T日)9:30-11:30、13:00-15:00,網下申購時間為8月16日(T日)9:30-15:00。

發行人此次募投項目預計使用募集資金金額為6億元。按此次發行價格9.37元/股和4534萬股的新股發行數量計算,若此次發行成功,預計發行人募集資金總額約4.25億元,扣除約4761.77萬元(不含税)的發行費用後,預計募集資金淨額3.77億元。

此次發行價格9.37元/股對應的發行人2021年扣除非經常性損益前後孰低的攤薄後市盈率為48.56倍,高於中證指數有限公司發佈的發行人所處行業最近一個月平均靜態市盈率,低於同行業可比公司扣非前歸母淨利潤對應的靜態市盈率平均水平,低於同行業可比公司扣非後歸母淨利潤對應的靜態市盈率平均水平。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account